Quality Assessment of Various Brands of Ciprofloxacin Hydrochloride Tablets Sold In Uyo Metropolis
Main Article Content
Abstract
Ciprofloxacin is a flouroquinoline antibiotic with a broad spectrum of activity used for the treatment of various bacterial infections including anthrax. The use of substandard or fake ciprofloxacin products will jeopardise their usefulness. Hence, the need for provisions of simple and cost-effective method(s) of assay that will encourage regular and quick sampling of ciprofloxacin tablets. Different brands of ciprofloxacin hydrochloride tablets purchased randomly from drug stores in the study centre, and coded A-J, were assayed for weight uniformity, friability, hardness, disintegration, dissolution rate using standard physical methods. Their percentage drug contents were determined using spectrophotometric and titrimetric methods. The spectrophotometric measurement was done at a wavelength of 276nm while the titrimetric method was based on oxidative reaction between ciprofloxacin and potassium permanganate yielding the oxide as a greyish pink colour at end point. All the brands met the requirements for weight uniformity, friability, disintegration and dissolution. Only one brand, sample E, failed the hardness test. The titrimetric and spectrophotometric assay showed that seven of the brands met the British Pharmacopoeia requirement for percentage drug content (95.0-105.0%). Statistical analysis showed no significant difference (p<0.05) between the results obtained from both the titrimetric and spectrophotometric methods. The two methods are reliable, simple and cost-effective and can be routinely used to assay ciprofloxacin tablets.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Adegbolagun, O. A., Olalade, O. A. and Osumah, S. E. (2007). Comparative Evaluation of the Biopharmaceutical and Chemical Equivalence of some Commercially Available Brands of Ciprofloxacin Hydrochloride Tablets. Tropical Journal of Pharmaceutical Research, 6 (3): 737-745.
American Academy of Pediatrics. (2015) Red Book: 2015 Report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village, IL: American Academy of Pediatrics.
American Medical Association (2001). Diagnosis and management of foodborne illnesses: a primer for physicians. MMWR Recomm Rep. 50(RR-2):1-69.
Andersson, M. I. and MacGowan, A. P. (2003). Development of the Quinolones. Journal of Antimicrobial Chemotherapy, 51 (1): 1-11.
Bearden, D. T. and Danziger, L. H. (2001). Mechanism of Action of and Resistance to Quinolones. Pharmacotherapy, 21 (10): 224-232.
British Pharmacopoeia (2008). Monographs on Medicinal and Pharmaceutical Substances. Her Majesty’s Stationery Office, London. 1: 534-537.
British Pharmacopoeia (2015). British Pharmacopoeia Commission, London. 3: 320.
Dixon TC, Meselson M, Guillemin J, Hanna PC. (1999). Anthrax. The New England Journal of Medicine 341:815-826. [PubMed 10477781]
Drugs.com (2018). Ciprofloxacin Monograph for Professionals. https://www.drugs.com/monograph/ciprofloxacin.html. Retrieved 28/04/18
Duggirala, A., Joseph, J., Sharma, S., Nutheti, R., Garg, P., Das, T. (2007). Activity of Newer Fluoroquinolones Against Gram-Positive and Gram-Negative Bacteria Isolated from Ocular Infections: An In Vitro Comparison. Indian Journal of Opthalmology, 55 (1): 15-19.
Getu, K and Awot, G.E (2010). Quality Assessment of the Commonly Prescribed Antimicrobial Drug, Ciprofloxacin Tablets, Marketed in Tigray, Ethiopia. MEJS Volume 2 (1): 93-107. DOI.10.4314/mejs.v2i1.49656
Ghelani R (2017). Ciprofloxacin Patient Information uses, dosage, warnings, side effects.
http://www.netdoctor.co.uk/medicines/infections/a28009/ciprofloxacin-uses-and- things-to-know/ Retrieved 24/04/2018
Igboasoiyi A.C., Attih E.E., Ofoefule S.I., Umoh E.D. and Udoh O.C. (2014). Spectrophotometric Determination of Ciprofalxocin Using Charge-Transfer Complexation Technique. International Journal of Innovative Research and Development. 3(11): 177-182
Jaman M., Chowdhury A. A. , Rana1 A. A., Masum S. M., Ferdous T., Rashid M. A. and Karim. M. M. (2015). In vitro evaluation of Ciprofloxacin Hydrochloride. Bangladesh J. Sci. Ind. Res. 50(4), 251-256.
Jantratid, E., Janssen, N., Reppas, C. and Dressman, J. B. (2008). Dissolution Media Simulation Conditions in the Proximal Human Gastrointestinal Tract: An Update. Pharmaceutical Resources, 25: 1663-1676.
Olaniyi A.O. and Ogungbamila F.O. (1998). Experimental Pharmaceutical Chemistry 2nd Reprint, Shaneson C.I. Limited, Ibadan
Shah V. P. (2001), Dissolution: a quality control test vs a bioequivalent test. Dissolution Technologies 8(4): 1–2.
Stamm, W E. and Norrby, S. R. (2001). Urinary Tract Infections: Disease Panorama and Challenges. The Journal of Infectious Diseases, 183 (1): S1-S4.
Uivarosi, V. (2013). Metal Complexes of Quinolone Antibiotics and their Applications. An Update. Molecules, 18 (9): 11153-11197.
United States Pharmacopoeia (USP). 24 NF 19. United States Pharmacopoeia Convention Incorporation , pp 1882-1883
United States Pharmacopoeia National Formulary USP 37NF 32. (2014). Ciprofloxacin Official Monograph, United States Pharmacopeial Convention 12601. Twinbrook, Parkway, Rockville MD 20852, 2:2355-2356
World Health Organization (2015). 19th WHO Model List of Essential Medicines, p. 8.